Abstract:SummaryIn this article a series of divalent and trivalent carbohydrate mimetics on the basis of an enantiopure aminopyran and of serinol is described. These aminopolyols are connected by amide bonds to carboxylic acid derived spacer units either by Schotten–Baumann acylation or by coupling employing HATU as reagent. The O-sulfation employing the SO3·DMF complex was optimized. It was crucial to follow this process by 700 MHz 1H NMR spectroscopy to ensure full conversion and to use a refined neutralization and p… Show more
“…[23,24] These studies demonstrated that the binding affinity to Lselectin increases with the epitopes' valency from monovalent epitopes like azidopyranes and azidoopexanes to their trivalent presentation. [24,25] It was determined that AuNS can be display 1000-5000 ligands on their surface, what results in even higher binding affinities at sub-nanomolar concentrations. [26] We thus hypothesize that the specific design of the ligand nanoparticle conjugate is a critical parameter which not only defines the efficiency of selectin inhibitors but also strongly regulates immune cell motility.…”
Due to their importance for the outcome of the inflammatory response, the motile myeloid cells are a focus of novel treatment options. The interplay of selectins and their ligands with leukocytes and endothelial cells, which mediate endothelial attachment and transmigration of immune cells, can be modulated by selectin-binding structures. Here, a library of selectin-targeting ligands coupled to either gold, silver, iron oxide nanospheres, or quantum dots of 5-10 nm in size is used to systematically study their impact on immune cell motility. The multivalent presentation of the carbohydrate mimetics results in very low sub-nanomolar binding to L-selectin. Using human primary monocytes, granulocytes, lymphocytes, and macrophages, it is shown that the ligands exhibit only minor effects on uptake, whereas the motility of leukocytes is critically affected as observed in migration assays evaluated by flow cytometry. The carbohydrate mimetic ring structure, sulfation, in particular, and the degree of ligand presentation, are constituents which cohere in this process. Specific carbohydrate ligands can thus selectively regulate leukocyte subsets. These data form the basis for advanced immunotherapy which inhibits the amplification of inflammation by restricting leukocyte influx to injured tissue sites. Furthermore, the targeting ligands may complement existing treatment options for inflammatory diseases.
“…[23,24] These studies demonstrated that the binding affinity to Lselectin increases with the epitopes' valency from monovalent epitopes like azidopyranes and azidoopexanes to their trivalent presentation. [24,25] It was determined that AuNS can be display 1000-5000 ligands on their surface, what results in even higher binding affinities at sub-nanomolar concentrations. [26] We thus hypothesize that the specific design of the ligand nanoparticle conjugate is a critical parameter which not only defines the efficiency of selectin inhibitors but also strongly regulates immune cell motility.…”
Due to their importance for the outcome of the inflammatory response, the motile myeloid cells are a focus of novel treatment options. The interplay of selectins and their ligands with leukocytes and endothelial cells, which mediate endothelial attachment and transmigration of immune cells, can be modulated by selectin-binding structures. Here, a library of selectin-targeting ligands coupled to either gold, silver, iron oxide nanospheres, or quantum dots of 5-10 nm in size is used to systematically study their impact on immune cell motility. The multivalent presentation of the carbohydrate mimetics results in very low sub-nanomolar binding to L-selectin. Using human primary monocytes, granulocytes, lymphocytes, and macrophages, it is shown that the ligands exhibit only minor effects on uptake, whereas the motility of leukocytes is critically affected as observed in migration assays evaluated by flow cytometry. The carbohydrate mimetic ring structure, sulfation, in particular, and the degree of ligand presentation, are constituents which cohere in this process. Specific carbohydrate ligands can thus selectively regulate leukocyte subsets. These data form the basis for advanced immunotherapy which inhibits the amplification of inflammation by restricting leukocyte influx to injured tissue sites. Furthermore, the targeting ligands may complement existing treatment options for inflammatory diseases.
“…[26] We recently reported optimizations of the O-sulfation step of multivalent carbohydrate mimetics connected with amide bonds and the commercially available sulfur trioxide-DMF complex was found to be the reagent of choice. [9] It was employed in (deuterated) DMF, thus allowing to follow the reaction progress with high-resolution 1 H-NMR spectroscopy. Here we present the successful application of this method for the O-sulfation of 3-azidopyran 2 and multivalent carbohydrate mimetics bearing 1,2,3-triazole units (Scheme 8).…”
Section: Resultsmentioning
confidence: 99%
“…bonds to compounds of general structure C with rigid or flexible linker units. [9] Similar compounds could be prepared by reductive amination. [10] In this report, we employ enantiopure 3-azido-substituted pyran 2 to synthesize the related divalent products D that are connected via 1,2,3-triazole units.…”
“…Amide bond formation to couple 21 and 22 proceeded well with benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) and N,N -diisopropylethylamine (DIPEA) as 80% spacer-bridged divalent ST14 antigen 23 was produced ( Scheme 3 B). 1-[Bis(dimethylamino)methylene]-1 H -1,2,3-triazolo[4,5- b ]pyridinium 3-oxide hexafluorophosphate 36 (HATU) also successfully catalyzed the coupling but produced some unidentified byproducts. Removal of all of the ester and ether protecting groups of 23 using the same procedure that was used for compound 4 yielded deprotected divalent ST14 2 , containing 2 RU.…”
Vaccines
based on isolated polysaccharides successfully protect
humans from bacterial pathogens such as
Streptococcus pneumoniae
. Because polysaccharide production and isolation can be technically
challenging, glycoconjugates containing synthetic antigens are an
attractive alternative. Typically, the shortest possible oligosaccharide
antigen is preferable as syntheses of longer structures are more difficult
and time-consuming. Combining several protective epitopes or polysaccharide
repeating units as blocks by bonds other than glycosidic linkages
would greatly reduce the synthetic effort if the immunological response
to the polysaccharide could be retained. To explore this concept,
we bridged the well-understood and immunologically potent RU of
S. pneumoniae
serotype 14 (ST14) with an aliphatic spacer
and conjugated it to the carrier protein CRM197. Mice immunized with
the spacer-bridged glycan conjugates produced high levels of specific
antibodies after just one or two vaccine doses, while the tetrasaccharide
repeating unit alone required three doses. The antibodies recognized
specifically ST14 CPS, while no significant antibody levels were raised
against the spacer or unrelated CPS. Synthetic vaccines generated
antibodies with opsonic activity. Mimicking polysaccharides by coupling
repeating unit antigens via an aliphatic spacer may prove useful also
for the development of other glycoconjugate vaccine candidates, thereby
reducing the synthetic complexity while enhancing a faster immune
response.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.